Global Diagnostic Electrophysiology Devices Market 2017-2021
About Diagnostic Electrophysiology Devices
Diagnostic EP devices are used for the diagnosis of cardiac abnormalities. These devices are used for the diagnosis and treatment of cardiovascular diseases (CVDs). Diagnostic EP devices are one of the fastest growing segments in the global medical devices market. X-ray systems, ECG devices, and diagnostic EP catheters generate a significant proportion of the revenue for the global diagnostic EP devices market. The growing incidence of CVDs such as cardiac arrhythmia drives the growth of the market.
Technavio’s analysts forecast the global diagnostic electrophysiology devices market to grow at a CAGR of 7.06% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global diagnostic electrophysiology devices market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Diagnostic Electrophysiology Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global diagnostic electrophysiology devices market: Boston Scientific, GE Healthcare, Philips Healthcare, and St. Jude Medical.
Other Prominent Vendors in the market are: Atrium Medical, Beijing Demax Medical Technology, Biosense Webster, BIOTRONIK, MicroPort Scientific, Millar, Siemens Healthineers, Spacelabs Healthcare, Sterlimed, SUZUKEN, Tyche MedTech, Vimecon, and Welch Allyn.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Use of mobile ECG monitoring systems. Technological advances have led to the development of compact and efficient devices. Large conventional ECG stress test systems have been miniaturized as portable systems. For instance, the Quinton 9500 Series, which is offered by Mortara Instrument, offers optimization of space in diagnostic rooms and laboratories. The system allows stress testing to be carried out in several settings. The system is wall mounted.”
According to the report, one of the major drivers for this market is Increasing adoption of portable EP systems. In November 2009, GE Healthcare launched portable ECG systems. Due to the lack of reimbursements in most emerging economies, key vendors are focusing on product enhancement and availability. In India, MAC-400, which is one of the top selling ECG systems, is manufactured and marketed by GE Healthcare. MAC-400 costs approximately $700-$800. It is provided with 3 channels. It is a low-cost portable ECG system that is available in the emerging economies. MACi is a single channel ECG device that costs between $300-$450.
Further, the report states that one of the major factors hindering the growth of this market is High cost of ablation procedures. Due to advances in technology, new tools and techniques are being used to perform ablation procedures. 3D electroanatomical mapping (EAM) and remote catheter monitoring are the most commonly used cardiac ablation procedures. Robotic technology assists electrophysiologists during interventional procedures. The conventional methods are challenging for electrophysiologists. Hence, advanced techniques have been developed.
Boston Scientific, GE Healthcare, Philips Healthcare, St. Jude Medical, Atrium Medical, Beijing Demax Medical Technology, Biosense Webster, BIOTRONIK, MicroPort Scientific, Millar, Siemens Healthineers, Spacelabs Healthcare, Sterlimed, SUZUKEN, Tyche MedTech, Vimecon, and Welch Allyn.